Sampreet Ramachandra

Active Investor

Therapeutic Area (Business Unit) Head - Hematology and Cell & Gene Therapies, Germany at Novartis

Bavaria

Sampreet Ramachandra, Therapeutic Area (Business Unit) Head - Hematology and Cell & Gene Therapies, Germany at Novartis is an active investor based in Bavaria. This profile covers what Sampreet Ramachandra backs, at which stage, and how founders can reach out in 2026.

Investor type: Angel
Stages: Pre SeedSeed
Invests in: Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseClimate & EnergyIoT & Connected DevicesManufacturing & Industrial
Location: Bavaria
Typical check: $150K
Past investments: 4

Notable investments

Planet WildFresenius KabiMeinspielzeugkisteMedipee

How to reach Sampreet Ramachandra

Angels and operators like Sampreet Ramachandra reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Sampreet Ramachandra invest in?

Sampreet Ramachandra invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Pre Seed and Seed. Match your sector and stage, then reach out with a personalized pitch.

How do I contact Sampreet Ramachandra?

Unlock Sampreet Ramachandra's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.